Table 1.
Baseline characteristics of the study participants according to fatty liver index (FLI) score.
| Variables | FLI Score | p-Value | ||
|---|---|---|---|---|
| <30 | 30–59 | ≥60 | ||
| Participants, n | 4550 | 2229 | 1185 | |
| Gender, n (%) | <0.001 | |||
| Men | 1561 (34.3) | 1043 (46.79) | 708 (59.75) | |
| Women | 2989 (65.7) | 1186 (53.21) | 477 (40.25) | |
| Age, y | 51.67 ± 0.13 | 53.86 ± 0.18 | 53.06 ± 0.25 | <0.001 |
| BMI, kg/m2 | 23.04 ± 0.04 | 26.02 ± 0.04 | 28.05 ± 0.09 | <0.001 |
| Drinking Status, n(%) | <0.001 | |||
| Never | 2615 (57.5) | 1131 (50.7) | 469 (39.6) | |
| Former | 287 (6.3) | 189 (8.5) | 102 (8.6) | |
| Current | 1648 (36.2) | 909 (40.8) | 614 (51.8) | |
| Smoking Status, n(%) | <0.001 | |||
| Never | 3231 (71.0) | 1346 (60.4) | 563 (47.5) | |
| Former | 516 (11.3) | 353 (15.8) | 244 (20.6) | |
| Current | 803 (17.7) | 530 (23.8) | 378 (31.9) | |
| Physical activity, MET-h/week | 23.25 ± 0.22 | 22.85 ± 0.32 | 22.52 ± 0.44 | 0.267 |
| AST | 25.91 ± 0.12 | 29.31 ± 0.38 | 35.99 ± 0.78 | <0.001 |
| ALT | 21.44 ± 0.15 | 30.26 ± 0.55 | 43.20 ± 1.45 | <0.001 |
| γ-GT | 16.38 ± 0.16 | 33.31 ± 0.73 | 74.41 ± 3.60 | <0.001 |
| Comorbidity, n(%) | ||||
| Hypertension | 1310 (28.9) | 1107 (49.7) | 716 (60.4) | <0.001 |
| Diabetes mellitus | 228 (5.0) | 255 (11.4) | 200 (16.9) | <0.001 |
| Hyperlipidemia | 1668 (36.7) | 1367 (61.3) | 859 (72.5) | <0.001 |
| Coronary artery disease | 23 (0.51) | 29 (1.3) | 13 (1.1) | 0.001 |
| Cancer | 59 (1.3) | 15 (0.7) | 12 (1.0) | 0.064 |
FLI: fatty liver index. Values are presented as mean ± standard error.